US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  
Antibodies in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 125 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 278 drug targets that are included ...  |  read more...
USD 6,746
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
11/3/2014 | published by: MarketsandMarkets
... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ...  |  read more...
USD 4,650
Bio Products Markets in China
11/1/2014 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Immune Checkpoint Inhibitors Market, 2014-2024
10/11/2014 | published by: Roots Analysis
... forms. Although cancer therapeutics continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards immunotherapeutics, ...  |  read more...
USD 1,899
Cardiovascular Peptides: Competitor Analysis
10/9/2014 | published by: La Merie Publishing
... in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the ...  |  read more...
USD 383
Global Biologic Therapeutics Market 2014-2018
10/29/2014 | published by: TechNavio - Infiniti Research Ltd.
... arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, ...  |  read more...
USD 3,500
Antibodies in Oncology Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 319 companies plus partners developing 764 antibody drugs in 1871 developmental projects in cancer. In addition, there are 8 suspended drugs ...  |  read more...
USD 6,746
Anti-Infective Peptides: Competitor Analysis
10/16/2014 | published by: La Merie Publishing
... of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent ...  |  read more...
USD 446
Global and China Monoclonal Antibody Industry Report, 2014-2019
10/21/2014 | published by: Research in China
... still one of biotech drugs with the fastest CAGR in recent years. Global blockbuster monoclonal antibody agents are still concentrated in Roche (Genentech), Amgen, AbbVie (Abbott), Johnson & Johnson, Novartis, etc. In 2013, the top ...  |  read more...
USD 2,600
Rabies Virus Vaccines, Antibodies and Immune Globulins: Competitor Analysis
9/21/2014 | published by: La Merie Publishing
... for prevention or treatment of Rabies virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication ...  |  read more...
USD 255
Anti-Inflammatory Peptides: Competitor Analysis
9/27/2014 | published by: La Merie Publishing
... 2014. Anti-Inflammatory peptides under development and on the market are used for treatment of diseases ranging from psoriasis, multiple sclerosis, transplantation and autoimmune diseases.Purchase of the downloadable pdf report includes a 6-month online access to ...  |  read more...
USD 319
Lyophilization Market by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical Procedure, & Others), Technology (Tray-style, Manifold, & Rotary) & Geography - Global Trends & Forecast to 2019
9/19/2014 | published by: MarketsandMarkets
... freeze-drying has significant applications in the food, pharmaceutical, and biotechnology industry and is used as a standard process to stabilize, store, and increase the shelf-life of products. In the food industry, freeze-drying is used for ...  |  read more...
USD 4,650
Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018
8/4/2014 | published by: MarketsandMarkets
... has witnessed various technological advancements to improve the sensitivity, reproducibility, quantifiability, and speed of western blot experiments. These advancements have led to a growth in the number of applications. Western blotting instruments and consumables have ...  |  read more...
USD 4,650
Monoclonal Antibodies Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ...  |  read more...
USD 2,995
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
8/4/2014 | published by: Roots Analysis
... more than USD 600 million in 2014. 2. About 45 molecules are currently in clinical development. Of these, approximately 25% are in Phase II or Phase III of development. As expected, the preclinical pipeline is ...  |  read more...
USD 1,899
Antibody Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Cancer Monoclonal Antibody Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... healthcare companies. Trends in cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal ...  |  read more...
USD 1,995
Chronic Lymphocytic Leukaemia: KOL Insight
5/27/2014 | published by: FirstWord
... radically altering the treatment algorithm. From Roche’s improved anti-CD20 monoclonal antibody Gazyva, to Pharmacyclics/Janssen Biotech’s Imbruvica, the treatment landscape is being transformed. Drivers of change Targeted therapies. Most significantly, KOLs predict that therapies from Roche, ...  |  read more...
USD 4,995
Antibody Partnering Terms and Agreements
6/1/2014 | published by: Current Partnering
... leading companies worldwide. Antibody Partnering Terms and Agreements includes: Trends in antibody dealmaking in the biopharma industry since 2009 Analysis of antibody deal structure Access to headline, upfront, milestone and royalty data Case studies of ...  |  read more...
USD 2,995
Conference Documentation: ADC Summit 2014
5/19/2014 | published by: SMI Publishing, Ltd
... Group is proud to announce that the ADC Summit 2013 conference will be returning to London in 2014. If you are interested in getting involved, please contact Dale Butler on 020 7827 6044 or via email  |  read more...
USD 788.78
Single-use Bioreactors Market, 2014-2024
4/23/2014 | published by: Roots Analysis
... the use of vials and pipettes, has emerged rapidly over the last decade. Today, this term surrounds a wide range of primarily plastic disposable technologies that are suitable for a wide variety of scales, from ...  |  read more...
USD 1,899
Drug Delivery Technologies Market Forecast 2014-2024
4/30/2014 | published by: Visiongain
... this market and related technologies? Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects. Our 202 page report provides 157 tables, charts, and graphs. Discover the most ...  |  read more...
USD 3,004
2/21/2014 | published by: MP Advisors
... of biosimilars with first ‘mab’ approval expected in 2014. This approval (Remicade- FY03/13A sales ¥73.5, infiximab from Nippon Kayaku by YE 14) will be marked as a milestone development because – 1.) it will open ...  |  read more...
USD 2,500
Bispecific Antibodies: Clinical Trial Tracker
2/13/2014 | published by: Roots Analysis
... different epitopes concurrently. Various technology platforms have been used for bsAbs production over the years. These platforms are based on the concepts of chemical crosslinking, hybrid hybridomas, with the latest being recombinant techniques. Different binding ...  |  read more...
USD 799
Competitor Analysis: EGF-R Antibodies –Biosimilars and Biosuperiors
3/4/2014 | published by: La Merie Publishing
... to treat solid tumors as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access ...  |  read more...
USD 347
< prev 1    3  4  5  6  7  8